leonurine has been researched along with Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Jin, H; Lou, Y; Mao, C; Wang, C; Wang, Q; Xu, H; Xu, T; Zhang, L; Zhang, Z | 1 |
| Cao, W; Chen, Z; Huang, Z; Li, Q; Liu, X; Qi, J; Wu, L; Xing, C; Yuan, Y; Zhang, B; Zhao, M; Zhu, J | 1 |
2 other study(ies) available for leonurine and Injuries
| Article | Year |
|---|---|
Upregulating mTOR/ERK signaling with leonurine for promoting angiogenesis and tissue regeneration in a full-thickness cutaneous wound model.
Topics: Angiogenesis Inducing Agents; Animals; Cell Movement; Disease Models, Animal; Drugs, Chinese Herbal; Extracellular Signal-Regulated MAP Kinases; Gallic Acid; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Rats; Regeneration; Signal Transduction; Skin; TOR Serine-Threonine Kinases; Wound Healing; Wounds and Injuries | 2018 |
Leonurine ameliorates adriamycin-induced podocyte injury via suppression of oxidative stress.
Topics: Animals; Apoptosis; Disease Models, Animal; Doxorubicin; Gallic Acid; Humans; Kidney; Kidney Diseases; Macrophages; Mice; Oxidative Stress; Podocytes; Proteinuria; Reactive Oxygen Species; Wounds and Injuries | 2018 |